The global bio-based polypropylene in medical devices market size was estimated at USD 10.1 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 19.5% from 2023 to 2030. Cost-effectiveness and advancement in technology are factors propelling the demand for bio-based polypropylene for the manufacturing of medical devices, especially used as implants across the human anatomy. Attributes including biocompatibility of bio-based polypropylene make the resin suitable for the manufacturing of surgical sutures. Medical sutures are not only limited to surgical procedures; they are additionally utilized to fix and heal wounds and mild concussion injuries. Such cases of injuries have propelled the demand for bio-based polypropylene for the manufacturing of surgical sutures, hence boosting the demand for bio-based polypropylene across the medical industry.
The increasing cases of hernia and increasing healthcare expenditure across the U.S. are anticipated to propel the demand for bio-based polypropylene surgical mesh for hernia repair. According to the American College of Surgeons (ACS), Healthcare Cost & Utilization Project (HCUP), and The United States Food & Drug Administration (FDA) in 2022, an estimated 611,000 ventral and approximately one million inguinal hernia repairs were performed.
Furthermore, according to the American Medical Association (AMA), healthcare expenditure in the U.S. will increase by 2.7% in 2021 to USD 4.3 trillion, which is anticipated to introduce technological advancements across the medical industry in the U.S., hence boosting the demand for bio-based polypropylene surgical mesh during the forecast period.
In terms of application, the heart valve structures segment dominated the market in 2022 with a revenue share of above 35%, followed by surgery sutures, and surgical mesh, respectively.
Rising heart ailments and increasing death rates due to cardiac arrest have propelled the demand for technological advancements across the cardiac sector of the medical industry globally. This is anticipated to boost the demand for bio-based polypropylene heart valve structures segment during the forecast period.
In terms of region, the Asia Pacific region dominated the market in 2022 with a revenue share of over 63% in 2022. The rising population, increasing healthcare expenditure, and advancement in technology across emerging economies such as China and India, are anticipated to fuel the demand for bio-based polypropylene in medical devices during the forecast period.
The Government of India announced a medical expenditure of USD 10.49 billion (Rs. 862 billion), as per the country’s 2022-23 budget release under the Ministry of Health and Family Welfare (MoHFW). Furthermore, technological advancement across nations including China, Japan, and Southeast Asia, has propelled the demand for utilization of bioplastics across medical applications.
Research activities across the market are focused on new materials that combine several properties and they are projected to gain wide acceptance in this industry in the coming years. Some prominent players in the global bio-based polypropylene in medical devices market include:
SABIC
LyondellBasell Industries Holdings B.V.
Mitsui Chemicals, Inc.
Borealis AG
Braskem
Total S.A.
Danimer Scientific
FKuR Kunststoff GmbH
GREENMANTRA
Avient Corporation
Report Attribute |
Details |
Market size value in 2023 |
USD 11.7 million |
Revenue forecast in 2030 |
USD 40.6 million |
Growth rate |
CAGR of 19.5% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Volume in tons, revenue in USD thousand/million, and CAGR from 2023 to 2030 |
Report coverage |
Revenue and volume forecast, company profiles, competitive landscape, growth factors, and trends |
Segments covered |
Application, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; The Netherlands; Spain; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Vietnam; Brazil; Argentina; Saudi Arabia; United Arab Emirates (UAE); South Africa |
Key companies profiled |
SABIC; LyondellBasell Industries Holdings B.V.; Mitsui Chemicals, Inc.; Borealis AG; Braskem; Total S.A.; Danimer Scientific; FKuR Kunststoff GmbH; GREENMANTRA; Avient Corporation |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue and volume growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bio-based polypropylene in medical devices market report based on application and region:
Application Outlook (Volume, Tons; Revenue, USD Thousand, 2018 - 2030)
Heart Valve Structures
Surgery Sutures
Surgical Mesh
Others
Regional Outlook (Volume, Tons; Revenue, USD Thousand, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
The Netherlands
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Vietnam
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
United Arab Emirates (UAE)
South Africa
b. The global bio-based polypropylene in medical devices market size was estimated at USD 10.12 million in 2022 and is expected to reach USD 11.70 million in 2023.
b. The global bio-based polypropylene in medical devices market is expected to grow at a compound annual growth rate of 19.5% from 2023 to 2030 to reach USD 40.63 million by 2030.
b. Heart Valve Structures accounted to the largest share in global bio-based polypropylene in medical devices market with revenue share of 35.50% in 2022.
b. Major players present across the market include SABIC; LyondellBasell Industries Holdings BV; Mitsui Chemicals, Inc.; Borealis AG; Braskem; Total S.A.; Danimer Scientific; FKuR Kunststoff GmbH; GREENMANTRA; and Avient Corporation.
b. Cost-effectiveness and advancement in technology are factors propelling the demand for bio-based polypropylene for manufacturing of medical devices, especially used as implants across the human anatomy.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.